Parainfluenza

6 registered clinical trials studyying Parainfluenza — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT NCT03808922	Ansun Biopharma, Inc.	Phase 3
Completed	Specific Respiratory Infections as Triggers of Acute Medical Events NCT02984280	University College, London	—
Completed	A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompr NCT01644877	Ansun Biopharma, Inc.	Phase 2
Completed	An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized For NCT01924793	Ansun Biopharma, Inc.	Phase 2
Completed	Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine NCT00641017	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Suspended	A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers NCT00186927	St. Jude Children's Research Hospital	Phase 1